info@synchemia.com | sales@synchemia.com 
9766925136 
Deucravacitinib Impurity 2
Specifications
Product name
Deucravacitinib Impurity 2
SRC CAT No
SRC-D3483
CAS No
722538-98-9
Mol.F.
C8H8N2O4
Mol.Wt.
196.2 g/mole
Related CAS No.
NA
Inv Status
CUSTOM SYNTHESIS
Chemical Structure
Product Overview
Description
Chemical Name
2-Methoxy-3-nitrobenzamide
HSN Code
38229010
Synonym
N.A
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compound.Deucravacitinib is used to treat moderate to severe plaque psoriasis, which is a skin disease with red patches and white scales that do not go away. It is given to patients who may receive other types of treatment, including pills, injection, or phototherapy (light treatment).
Deucravacitinib Impurity 2 CAS NO: 722538-98-9 chemically represented as 2-Methoxy-3-nitrobenzamide.Synchemia is the leading manufacturing and exporter of Deucravacitinib Impurity 2. We supply Deucravacitinib Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Related Products
Deucravacitinib Impurity 17
| CAT No | SRC-D3498 |
| CAS No | 1352925-63-3 |
| Mol.F. | C7H8N2O4 |
| Mol.Wt. | 184.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 18
| CAT No | SRC-D3499 |
| CAS No | 2761695-60-5 |
| Mol.F. | C17H17ClN6O3 |
| Mol.Wt. | 388.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 19
| CAT No | SRC-D3500 |
| CAS No | 2417138-49-7 |
| Mol.F. | C16H16ClN7O2 |
| Mol.Wt. | 373.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 20
| CAT No | SRC-D3501 |
| CAS No | 2245111-21-9 |
| Mol.F. | C10H9ClN4O3 |
| Mol.Wt. | 268.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 21
| CAT No | SRC-D3502 |
| CAS No | 3054860-97-5 |
| Mol.F. | C10H11ClN4O |
| Mol.Wt. | 238.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 22
| CAT No | SRC-D3503 |
| CAS No | 679406-03-2 |
| Mol.F. | C7H6Cl2N2O2 |
| Mol.Wt. | 221.0 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 24
| CAT No | SRC-D3504 |
| CAS No | NA |
| Mol.F. | C10H11N3O |
| Mol.Wt. | 189.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 25
| CAT No | SRC-D3505 |
| CAS No | NA |
| Mol.F. | C8H10N2OS |
| Mol.Wt. | 182.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 26
| CAT No | SRC-D3506 |
| CAS No | 2245111-18-4 |
| Mol.F. | C19H19N7O4 |
| Mol.Wt. | 409.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 27
| CAT No | SRC-D3507 |
| CAS No | 1040246-87-4 |
| Mol.F. | C5H2Cl2N2O2 |
| Mol.Wt. | 193.0 g/mole |
| INV STATUS | UNDER SYNTHESIS |
Deucravacitinib Impurity 28
| CAT No | SRC-D3508 |
| CAS No | 1261798-87-1 |
| Mol.F. | C5H3ClN2O2 |
| Mol.Wt. | 158.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 29
| CAT No | SRC-D3509 |
| CAS No | 1509180-81-7 |
| Mol.F. | C5H3ClN2O3 |
| Mol.Wt. | 174.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 30
| CAT No | SRC-D3510 |
| CAS No | 1782896-18-7 |
| Mol.F. | C5H3ClN2O3 |
| Mol.Wt. | 174.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 31
| CAT No | SRC-D3511 |
| CAS No | 1823277-97-9 |
| Mol.F. | C5H4N2O4 |
| Mol.Wt. | 156.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 32
| CAT No | SRC-D3512 |
| CAS No | 3026065-02-8 |
| Mol.F. | C9H10N4O |
| Mol.Wt. | 190.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Deucravacitinib Impurity 33
| CAT No | SRC-D3513 |
| CAS No | 3030727-45-5 |
| Mol.F. | C11H14N4O |
| Mol.Wt. | 218.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
